UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
$114.46
arrow_downward
-0.87%(-1.01) 1D
Okt 16, 4:00:00 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa UCBJY...
Buksan
$114.95
Mataas
$115.28
Mababa
$114.23
Mkt. cap
39.80B
Avg. na dami
53.31K
Dami
70.57K
Mataas nang 52-wk
$168.76
Mababa nang 52-wk
$110.55
Beta
0.57
Mga natitirang share
389.01M
Bilang ng mga empleyado
9K
Buksan
$114.95
Mataas
$115.28
Mababa
$114.23
Mkt. cap
39.80B
Avg. na dami
53.31K
Dami
70.57K
Mataas nang 52-wk
$168.76
Mababa nang 52-wk
$110.55
Beta
0.57
Mga natitirang share
389.01M
Bilang ng mga empleyado
9K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
MarketWatch
·
15 oras ang nakalipas
These surprising stocks could be some of the biggest drivers of S&P 500 earnings growth
Bloomberg.com
·
7 oras ang nakalipas
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
24/7 Wall St.
·
5 araw ang nakalipas
These 3 International Dividend ETFs Outyield SCHD and Are Beating the S&P 500 Over the Past Year
MarketWatch
·
1 buwan ang nakalipas
Bloom Energy was just named to the S&P 500. These other stocks are joining the index as well.
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
Tungkol sa UCB Unsponsored Belgium ADR